Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

SBFM Sunshine Biopharma Inc

2,86

0,13 (4,76%)

29 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Sunshine Biopharma (NASDAQ:SBFM)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Sunshine Biopharma Charts.

Sunshine Biopharma (NASDAQ:SBFM)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Sunshine Biopharma Charts.

News Sunshine Biopharma Inc

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Dienstag 20 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 19 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 16 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Mittwoch 14 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 12 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements
Donnerstag 11 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 März 2024 (9 Monate vor) • Edgar (US Regulatory)

Form PRE 14C - Other preliminary information statements
Dienstag 5 März 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (9 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 23 Februar 2024 (9 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 21 Februar 2024 (9 Monate vor) • Edgar (US Regulatory)

Form PRE 14C - Other preliminary information statements
Mittwoch 21 Februar 2024 (9 Monate vor) • Edgar (US Regulatory)

Weitere Sunshine Biopharma Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen